Together with findings that osimertinib increased the IGF-1R protein level, these results strongly suggest that an increased amount of IGF-1R, which maintains the association with EGFR and Gab1, may restore survival signals in AXL-low-expressing EGFR-mutated lung cancer cells exposed to osimertinib. This evidence concerns the gene EGFR and lung carcinoma.